Trial results posted: Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

ClinicalTrials.gov records the first posting of results for study NCT04502030 on 2026-11-02. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

• The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health